Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Bispecific Antibody cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
INDIANAPOLIS, INDIANA, April 27, 2026 Elanco Animal Health has received Emergency Use Authorization (EUA) from the U.S. Food and...
AMSTERDAM, Netherlands, April 17, 2026 The European Medicines Agency (EMA), through its Committee for Veterinary Medicinal Products (CVMP), has...
INGELHEIM, GERMANY, April 13, 2026 Boehringer Ingelheim has introduced LENZELTA®, a new veterinary vaccine designed to prevent mastitis in...
LYON, France, April 09, 2026 Boehringer Ingelheim has announced its continued support for Ecuador’s national effort to eliminate dog-mediated...
RALEIGH, NC, March 30, 2026 The AKC Canine Health Foundation (CHF) has announced a strategic collaboration with the educational...
Ann Arbor, Michigan, March 16, 2026 Zomedica Corp., a leading provider of veterinary diagnostic and therapeutic solutions, reported record...
Rahway, New Jersey, USA — February 25, 2026 The U.S. Food and Drug Administration (FDA) has approved NUMELVI™ (atinvicitinib...
BASTROP, Texas, Feb. 2, 2026 — Low Cost Pet Vax announced the launch of an affordable community pet vaccination...
